Background The presence of prior malignancies at the time of cutaneous malignant melanoma diagnosis may be a critical determinant of patient survival. The present study evaluated the clinical and economic impact of prevalent cancers at the time of cutaneous melanoma diagnosis. Methods This population-based retrospectiv...
Alessandra Buja, S. Guzzinati, Chiara Trevisiol et al.· Frontiers in Oncology· 0 citations
Simple Summary Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced melanoma, leading to substantial and durable improvements in patient survival. However, these agents may also trigger immune-related cardiovascular toxicities, which, although uncommon, can be severe and potentially fatal....
Andrea Bottardi, Gabriele Busin, Lam Nguyen et al.· Cancers· 0 citations
